Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-13.18%
202439.96%
202326.42%
20227.52%
2021-1.91%
202049.61%
2019-35.28%
2018-25.15%
201732.55%
201621.73%